Two-component signal transduction systems are the primary means by which bacteria sense environmental change and integrate an adaptive response. In pathogenic bacteria, 2-component signal transduction (TCST) kinases are involved in the expression of virulence and antibiotic resistance. This makes bacterial TCST systems attractive targets for pharmacologic intervention. This paper describes a fluorescence polarization assay that quantifies the binding between bacterial DNA promoter segments and their cognate response regulator proteins. Using the VanRSTCST system from Enterococcus faecium, which encodes vancomycin resistance, the authors demonstrate inhibition of response regulator protein/promoter segment binding with a known inhibitor. Observed binding constants were comparable to those reported in surface plasmon resonance measurements and gel shift measurements. (Journal of Biomolecular Screening 2005:270-274) 
anti-infective leads. [10] [11] [12] TCST kinases may be less suitable targets than their cognate response regulators owing to phosphorylation by a promiscuous kinase from another system or to nonspecific phosphorylation from small phosphoryl group donors in the cytosolic fraction.
Conservation of genetic sequences is another issue; the N terminal signal domain of sensor kinases from a given TCST family domain displays considerable variation. In contrast, the region of the cognate response regulator that interacts with the phopshoryl donor region of the sensor kinase is highly conserved as is the promoter binding region of the response regulator. 13 This suggests that pharmacological intervention aimed at response regulators would be more difficult to circumvent.
Previously, we used VanRS as a test system to characterize response regulator activity and its inhibition based on mobility shift analysis using 32 P labeled promoter DNA fragments. 14 In this work, we extend these studies and demonstrate a homogeneous assay based on fluorescence polarization (FP) for antimicrobial lead drug discovery. FP assays are solution based and homogeneous, desirable attributes for a high-throughput assay. molecular rotation. When the ligand binds to a target, molecular rotation decreases and polarization increases. This suggests that the best results in an FP assay will be realized when the labeled ligand (probe) is small with respect to the target. Nonetheless, acceptable results may be obtained when the two are of comparable mass.
In this work, we chose a fluorescein-labeled DNA promoter segment as probe molecule, whereas a relatively large response regulator protein served as the target. Use of the smaller promoter segment as a probe instead of the entire promoter sequence resulted in better assay performance and facilitated comparison with the earlier surface plasmon resonance (SPR) study. 15 Previously, LeTilly and Royer reported FP measurements of protein-DNA actions in a bacterial system. 16 They chose to study the interaction of a bacterial repressor protein, the tryptophan repressor, with a labeled oligonucleotide containing one of its operator sequences. Here, we extend this approach to response regulator protein-DNA promoter interactions involved in the regulation of antimicrobial resistance.
Purity is an issue when designing a labeled probe for FP. In this assay, 5′ double-stranded 18 mer DNA promoter segments were used. Selective labeling of the 5′ base is readily accomplished on the DNA synthesizer; oligonucleotides labeled in this fashion are sufficiently pure for FP "off the column."
Although we report an assay based on DNA-protein interaction, some caveats applicable to TCST FP assays using labeled peptides or proteins should be mentioned. The probe molecule should be labeled at only 1 site if reliable results are expected. Invariably, the labeling reagents used on peptides and proteins produce some side chain labeling (i.e., lysyl groups). This can be controlled somewhat by adjusting the relative concentration of labeling reagent and substrate. A postlabeling purification step is mandatory, using either high-performance liquid chromatography or thin layer chromatography. The last method is effective for many peptides and offers both economy and simplicity. 17 Just as it is important to use a pure probe, it is equally important to use high-purity solvents and reagents: Impurities with fluorescence emission falling inside the passband of the instrument's detector can give spurious results. Any suspect reagents should be checked against a blank charged with high-purity distilled and deionized water. Total fluorescence should be comparable if the reagent is sufficiently pure.
The relative concentrations of probe and target are important as well. Consider a ligand-receptor interaction with binding constant K d . The percentage of bound probe varies with both the probe concentration and the receptor concentration. In an FP assay, the greatest change in polarization will be seen when the percentage of bound probe changes from a few percent or less to greater than 90% as receptor concentration is increased. This condition is easily realized by fixing the total probe concentration at 0.1 K d or less while varying the concentration of receptor from ≤0.05 K d to ≈10 to 50 K d . 17 In most cases, the probe condition will be satisfied by selecting a total probe concentration that is just high enough to give an acceptable signal-to-noise ratio. This concentration may be determined by measuring total probe fluorescence relative to a blank well over a range of probe concentrations. Most fluorescein-labeled probes will give a good signal-to-noise ratio on the Wallac instrument at a concentration of about 12 to 15 nM. If an appreciably lower probe concentration is needed, a label with a higher quantum efficiency may be required. Fluorescein is a popular choice because it offers acceptable performance in most situations at low cost.
The buffer system used in this assay was chosen because it was used in both a previously reported gel shift mobility study and the previously reported SPR study. 15 
MATERIALS AND METHODS

Tagged oligonucleotides
5′ fluorescein tagged 18-mer oligonucleotide promoter segments based on the vanH promoter studies of Holman et al. were used as probe-fluorophores in all FP experiments. 8 This choice was made because site-specific dye tagging of oligonucleotides is easier than dye tagging of proteins and because the mass of the promoter segments was considerably less than that of the glutathione-S-transferase (GST) fusion protein. The following oligonucleotides were synthesized at the University of Wisconsin Biotechnology Center using an ABI DNA synthesizer. After synthesis, each strand was dissolved in deionized water to a concentration of 8 µM and stored at -20°C. Prior to experiments, oligos were annealed by mixing equimolar amounts of forward and reverse strands and heating in a 80°C bath for 10 min, followed by slow cooling to room temperature.
Response regulator protein
The VanR response regulator protein was expressed as a GST fusion protein using the complete VanR sequence and the plasmid pGEX-2TK (Amersham Pharmacia Biotech) in Escherichia coli BL21 Lambda DE3 cells as reported previously. 14 The fusion protein was stored at -60°C prior to use.
Compound A
(2,3,4)-trifluorphenylisothiazolone (Maybridge Chemical Company) was stored at -20°C at a concentration of 1.0 mM. It was used without further purification. This compound was reported by Roychoudhury et al. as part of a systematic search for inhibitors of signal transduction that would target alginate biosynthesis in Pseudomonas aeruginosa. 18 Chemically, this compound is a halophenyl isothiazolone; it inhibits the algD promoter in P. aeruginosa. In fact, compound A inhibits several other His → Asp phosphorelay systems. 18 In a previous study, this lab showed that compound A inhibits the interaction of VanR and VanS by interfering with the ability of VanR to accept phosphoryl groups rather than by interfering with the ability of VanS to donate phosphoryl groups. 19 
FP measurements
All FP experiments were performed on a Wallac Victor Instrument (Wallac, Turku, Finland) run in FP mode with a measurement time of 1 s per well. Excitation wavelength was 485 nM, and emission wavelength was 515 nM. All experiments were run at room temperature, which was about 22°C at our facility.
The reaction mixtures, in a total volume of 40 µL, contained 13 nM fluorescein-labeled PvanH2 and increasing amounts of GST-VanR in 1X gel shift buffer (GSB), as indicated on the abscissa. GSB consists of 20 mM HEPES, 5 mM MgCl 2 , 0.1 mM EDTA, and 0.5 CaCl 2 at pH 7.2. GSB was chosen as it was used in the gel mobility retardation experiments described in Ulijasz et al. 14 Black 384-well microplates (Corning) were used in all experiments. First, the wells were charged with 30 µL of 1X GSB. Next, 45 µL of VanR-GST was added to the 1st well and mixed with the 1X GSB by pipetting up and down 7 times. An equal volume of mixed solution was transferred to the next well, and the serial dilution was continued to the last well, where 45 µL was discarded after mixing. The oligo solution was prepared by adding concentrated stock solution to 1X GSB buffer in a plastic trough and mixing by gentle side-to-side agitation. After mixing, 10 µL oligo solution was added to each well with a multichannel pipette. Mixing was achieved by multiple cycles of up and down pipetting. Each plate was allowed to equilibrate for 30 min at room temperature prior to measurements. A blank solution of 40 µL of 1.0 µM GST-VanR in 1X GSB was used for correction of raw-intensity data. Experiments using compound A or VanS c were carried out by adding a solution containing the required amount of inhibitor and the required amount of oligos to each well with a multichannel pipette.
The G factor was obtained by collecting parallel and perpendicular components of fluorescence from an 8 nM solution of fluorescein in ddH 2 O. For these measurements, a 45-µL well of ddH2O was used as a blank.
For inhibitor experiments, equal amounts of compound A were added to all wells for a given run. A family of curves sufficient for measuring K i was generated by running the experiment with different concentrations of compound A, all other parameters being fixed.
RESULTS AND DISCUSSION
In E. faecium, response regulator VanR and its cognate histidine kinase VanS control transcription of the vanRS and vanHAX genes by binding to multiple promoter binding regions. 8, 9, 20 When the vanHAX gene cluster is activated, D-Ala-D-Lac is introduced into the cell wall precursor; glycopeptide antibiotics such as vancomycin have a markedly lower affinity for the modified cell wall.
Compound A has been shown to inhibit phosphoryl transfer from VanS~P to VanR by its action on VanR. 19 As a consequence of inhibition by compound A, VanS~P accumulates, suggesting that Asp-55 on the amino terminal regulatory subunit of VanR is unable to accept phosphate from VanS.
Compound A also inhibits the binding of VanR and VanR~P to its DNA promoter site. This has been demonstrated by both surface plasmon resonance studies and agarose gel electrophoresis mobility retardation studies, suggesting a wider scope of action involving the VanR protein DNA binding domain as well. 14, 19 The regulatory regions of vanRS and vanHAX contain promoter-binding regions designated R1, H1, and H2 as shown in Figure 1 ble-stranded, fluorescein-tagged 18-mer based on H2 was used as the target sequence for VanR promoter-binding studies. As shown in Figure 2 , compound A inhibits the binding of PvanH2 to GST-VanR. The K d for the control reaction was 30 nM. This result is comparable to promoter-response regulator interaction values reported by Mattison and Kenney 21 for the OmpR bacterial TCST. It is also comparable to the value of 40 nM reported for the binding of the entire vanHAX promoter region to VanR~P in a previously reported gel shift measurement 14 and to the value of approximately 150 nM reported for the binding of GST-VanR~P to each of the 3 promoter segments in the previously reported SPR study. 15 Compound A at 1.5, 2.5, and 5.0 µM increased the apparent K d to 35 nM, 150 nM, and 500 nM. This compares with the 4to 5-fold increase reported for the apparent K d for the GST-VanR~P-promoter segment interactions reported in the SPR study. The structure of compound A is shown in the figure insert.
In Figure 3 , the interaction of GST-VanR with PvanH2 is inhibited by VanS c , the soluble (cytosolic) domain of the cognate sensor-kinase protein, VanS. The inhibition of the GST-VanR~P and PvanH by synthetic peptide analogues of VanS c was previously studied using gel shift measurements. Here, we demonstrate the feasibility of screening mimetic peptides with an FP assay instead of the more laborious gel shift method. As mentioned previously, labeled peptides might be chosen as probes in some situations. Soluble VanS c at 0.27, 0.53, and 1.77 µM increased the apparent K d to 80 nM, 150 nM, and 320 nM.
The results from these binding studies indicate that this assay is suitable for high-throughput screening of compounds capable of inhibiting the formation of VanR-PvanH complexes; extension to other response regulator-promoter interactions should be straightforward. In addition, the assay provides for quantification of test compound inhibition at any chosen set of experimental parameters and is performed in a homogenous phase. By formatting the assay on the basis of 1 µl of a 1 mM stock library concentration in a 50-µl test reaction, up to 20 µM drug candidate in the test reaction can be achieved. Because FP uses fluorescence labeling, the use of radio isotopes is avoided. 
